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INVITED COMMENTARYCommentaryon ‘ADecisionAidRegarding TreatmentOptions for Patientswith
an Asymptomatic Abdominal Aortic Aneurysm: A Randomised Clinical Trial’
M. Björck
Department of Surgical Sciences, Uppsala University, Uppsala, SwedenIn this issue of European Journal of Vascular and Endovas-
cular Surgery, Knops et al. report the results of a rando-
mised trial.1 They address an important issue for everyday
vascular surgery: how can we better inform patients with
abdominal aortic aneurysm (AAA), and involve them
actively in the surgical decision-making? The study was
performed in six vascular centres in Amsterdam. Patients
who were recently diagnosed with an AAA with a diameter
of 4 cm or more were randomised between standard care
and adding an interactive CD-ROM informing them of the
pros and cons of elective surgery and watchful waiting.
The results are quite interesting. The patients who
received the extra standardised information had better
knowledge, but anxiety, satisfaction, and decisional conﬂict
scores did not differ between the groups. How should we
interpret these ﬁndings? Having an AAA is a worrying sit-
uation, and being better informed does not necessarily
reduce anxiety. To decide between two alternatives that
both include a risk of death is a difﬁcult existential conﬂict.
A patient attitude that was quite common in the 1970s
when I started to practise surgery, was that the patient
placed his fate in the hands of the surgeon. “Doctor, you
know best!”, was a frequent comment. Strangely enough,
these patients gave the impression of having great conﬁ-
dence in the young surgeon who was to operate on them,
and did not seek more information. We still meet these
patients, although this is increasingly uncommon.
The colleagues in Amsterdam are to be congratulated for
having performed another important clinical study, and a
randomised controlled trial, giving us the highest level of
evidence. Yet there are, as always in research, some limita-
tions. An outstanding issue, thatmay limit the generalisability
of the investigation, is the quality of “standard care.” We
know from other studies on interventions that standard care
has the tendency to improve during the time that an inves-
tigation is carried out. It is possible that the surgeons
participating in the study may have improved their practice,
informing their patients better than at baseline, before the
studywas initiated. Unfortunately, there are no baseline data.
Wehave investigatedqualityof life (QoL)withShort-Form36
before andafter screening forAAA, thuswith true baselinedata
before the ultrasound investigation of the aorta was per-
formed,2 and 12months later.We found that among thosewhoDOI of original article: http://dx.doi.org/10.1016/j.ejvs.2014.04.016
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http://dx.doi.org/10.1016/j.ejvs.2014.06.033had an age-adjusted normal QoL prior to screening and who
were found to have the disease, no negative effects were
observed on QoL. Those who suffered a low QOL prior to
screening, however, had their QoL further impaired by the
diagnosis of an AAA. Thus, there seems to exist a small
vulnerable subgroup of patients, which, among psychiatrists, is
sometimes labelled “the orchids”, as opposed to the “the
dandelions,” that grow through the concrete.To further explore
the explanation for this negative reaction, we performed a
qualitative investigationof someof thosepatientswhohadhad
their QoL further impaired 12 months after AAA screening,
using thematic content analysis.3 The investigation showed
that these patients all had multiple other physical and/or
mental diseases that overshadowed the AAA. Maybe infor-
mation given by a sensitive clinician is more appropriate than
standardized information? This way the information can be
individualised. In particular, patients with an AAA that is less
than 5.5 cmneed to be reassured that the riskof rupture is very
small, and this reassurance is probably better delivered by a
doctor than by a machine.
The Amsterdam study highlights that we need to investigate
further how to inform patients about AAA, in order not to have
unnecessary negative effects on QoL. The fact that AAA
screening is becoming part of routine health care in many
countries4,5makes this issue evenmore important.Weneed to
address thisﬁeld of researchwith amultidisciplinary approach,
taking advantage of previous experiences in behavioural sci-
ences and nursing. Most of the work is still ahead of us.REFERENCES
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